AnaCardio

AnaCardio is a privately held clinical stage biopharmaceutical company developing novel drugs to treat heart failure.

AnaCardio AB is a privately held Swedish, clinical stage biopharmaceutical company developing novel drugs to treat heart failure. AnaCardio was founded based on ground-breaking research from Karolinska Institutet showing improved.

Read more about AnaCardio here

DRIVE incubator alumni Pharmaceuticals
Go back